Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19

Clinical trial NCT04376814 · COMPLETED

Trial details

NCT number: NCT04376814
Sponsor: Baqiyatallah Medical Sciences University
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

COVID-19 Favipiravir Kaletra Hydroxychloroquine Lopinavir/Ritonavir

Start date: 2020-03-29
Primary completion: 2020-04-05
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.